-
1
-
-
22744433595
-
-
Merck, Whitehouse Station, NJ
-
For leading references to bioactive α-arylalkanoic acid derivatives, see: a) "Fenvalerate": The Merck Index, 13th ed., Merck, Whitehouse Station, NJ, 2001, pp. 710-711;
-
(2001)
"Fenvalerate": The Merck Index, 13th Ed.
, pp. 710-711
-
-
-
2
-
-
0041565245
-
-
b) J. Robichaud, R. Oballa, P. Prasit, J.-P. Falgueyret, M. D. Percival, G. Wesolowski, S. B. Rodan, D. Kimmel, C Johnson, C. Bryant, S. Venkatraman, E. Setti, R. Mendonca, J. T. Palmer, J. Med. Chem. 2003, 46, 3709-3727;
-
(2003)
J. Med. Chem.
, vol.46
, pp. 3709-3727
-
-
Robichaud, J.1
Oballa, R.2
Prasit, P.3
Falgueyret, J.-P.4
Percival, M.D.5
Wesolowski, G.6
Rodan, S.B.7
Kimmel, D.8
Johnson, C.9
Bryant, C.10
Venkatraman, S.11
Setti, E.12
Mendonca, R.13
Palmer, J.T.14
-
4
-
-
0008339103
-
-
d) C. D. W. Brooks, A. O. Stewart, T. Kolasa, A. Basha, P. Bhatia, J. D. Ratajczyk, R. A. Craig, D. Gunn, R. R. Harris, J. B. Bouska, P. E. Malo, R. L. Bell, G. W. Carter, Pure Appl. Chem. 1998, 70, 271-274;
-
(1998)
Pure Appl. Chem.
, vol.70
, pp. 271-274
-
-
Brooks, C.D.W.1
Stewart, A.O.2
Kolasa, T.3
Basha, A.4
Bhatia, P.5
Ratajczyk, J.D.6
Craig, R.A.7
Gunn, D.8
Harris, R.R.9
Bouska, J.B.10
Malo, P.E.11
Bell, R.L.12
Carter, G.W.13
-
5
-
-
0026470747
-
-
e) K. Brune, G. Geisslinger, S. Menzel-Soglowek, J. Clin. Pharmacol. 1992, 32, 944-952;
-
(1992)
J. Clin. Pharmacol.
, vol.32
, pp. 944-952
-
-
Brune, K.1
Geisslinger, G.2
Menzel-Soglowek, S.3
-
6
-
-
0026567443
-
-
f) H. R. Sonawane, N. S. Bellur, J. R. Ahuja, D. G. Kulkarni, Tetrahedron: Asymmetry 1992, 3, 163-192;
-
(1992)
Tetrahedron: Asymmetry
, vol.3
, pp. 163-192
-
-
Sonawane, H.R.1
Bellur, N.S.2
Ahuja, J.R.3
Kulkarni, D.G.4
-
7
-
-
0022543713
-
-
g) J.-P. Rieu, A. Boucherle, H. Cousse, G. Mouzin, Tetrahedron 1986, 42, 4095-4131;
-
(1986)
Tetrahedron
, vol.42
, pp. 4095-4131
-
-
Rieu, J.-P.1
Boucherle, A.2
Cousse, H.3
Mouzin, G.4
-
8
-
-
0019014701
-
-
h) N. Bodor, R. Woods, C. Raper, P. Kearney, J. J. Kaminski, J. Med. Chem. 1980, 23, 474-480.
-
(1980)
J. Med. Chem.
, vol.23
, pp. 474-480
-
-
Bodor, N.1
Woods, R.2
Raper, C.3
Kearney, P.4
Kaminski, J.J.5
-
9
-
-
0024430786
-
-
For examples of industrial interest in using asymmetric additions to ketenes to produce arylpropionic acid derivatives, see: a) R. D. Larsen, E. G. Corley, P. Davis, P. J. Reider, E. J. J. Grabowski, J. Am. Chem. Soc. 1989, 111, 7650-7651;
-
(1989)
J. Am. Chem. Soc.
, vol.111
, pp. 7650-7651
-
-
Larsen, R.D.1
Corley, E.G.2
Davis, P.3
Reider, P.J.4
Grabowski, E.J.J.5
-
10
-
-
22744435829
-
-
(Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, New York, chapt. 15
-
b) C. G. M. Villa, S. P. Panossian in Chirality in Industry (Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, New York, 1992, chapt. 15;
-
(1992)
Chirality in Industry
-
-
Villa, C.G.M.1
Panossian, S.P.2
-
11
-
-
22744443075
-
-
(Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, New York, chapt. 3
-
c) G. P. Stahly, R. M. Starrett in Chirality in Industry 11 (Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, New York, 1997, chapt. 3.
-
(1997)
Chirality in Industry 11
-
-
Stahly, G.P.1
Starrett, R.M.2
-
12
-
-
84982337484
-
-
For pioneering studies of asymmetric catalysis of this process, see: a) H. Pracejus, Justus Liebigs Ann. Chem. 1960, 634, 9-22;
-
(1960)
Justus Liebigs Ann. Chem.
, vol.634
, pp. 9-22
-
-
Pracejus, H.1
-
14
-
-
0033599548
-
-
For our studies of asymmetric catalysis of this process, see: a) B. L. Hodous, J. C. Ruble, G. C. Fu, J. Am. Chem. Soc. 1999, 121, 2637-2638;
-
(1999)
J. Am. Chem. Soc.
, vol.121
, pp. 2637-2638
-
-
Hodous, B.L.1
Ruble, J.C.2
Fu, G.C.3
-
16
-
-
16244399760
-
-
(Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto), Springer, New York
-
For reviews of enantioselective protonations of enols/enolates, see: a) A. Yanagisawa in Comprehensive Asymmetric Catalysis (Supplement 2) (Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto), Springer, New York, 2004, pp. 125-132;
-
(2004)
Comprehensive Asymmetric Catalysis (Supplement 2)
, pp. 125-132
-
-
Yanagisawa, A.1
-
17
-
-
28644442668
-
-
(Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto), Springer, New York, chapt. 34.2
-
A. Yanagisawa, H. Yamamoto in Comprehensive Asymmetric Catalysis (Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto), Springer, New York, 1999, chapt. 34.2;
-
(1999)
Comprehensive Asymmetric Catalysis
-
-
Yanagisawa, A.1
Yamamoto, H.2
-
19
-
-
22744453559
-
-
(Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, New York, chapt. 16
-
c) C. Fehr in Chirality in Industry 11 (Eds.: A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, New York, 1997, chapt. 16;
-
(1997)
Chirality in Industry 11
-
-
Fehr, C.1
-
20
-
-
0000530876
-
-
C. Fehr, Angew. Chem. 1996, 108, 2726-2748;
-
(1996)
Angew. Chem.
, vol.108
, pp. 2726-2748
-
-
Fehr, C.1
-
22
-
-
4143138630
-
-
For leading references, see: G. C Fu, Acc. Chem. Res. 2004, 37, 542-547.
-
(2004)
Acc. Chem. Res.
, vol.37
, pp. 542-547
-
-
Fu, G.C.1
-
23
-
-
0343362717
-
-
2) and pyridine, see: K. W. Rosenmund, G. Kositzke, H. Bach, Chem. Ber. 1959, 92, 494-501.
-
(1959)
Chem. Ber.
, vol.92
, pp. 494-501
-
-
Rosenmund, K.W.1
Kositzke, G.2
Bach, H.3
-
24
-
-
22744436814
-
-
In contrast, treatment of a ketene with catalyst 1 and a non-enolizable aldehyde (e.g., PhCHO) leads to [2+2] cycloaddition to generate a β-lactone with good stereoselectivity: J. E. Wilson, G. C. Fu, Angew. Chem. 2004, 116, 6518-6520;
-
(2004)
Angew. Chem.
, vol.116
, pp. 6518-6520
-
-
Wilson, J.E.1
Fu, G.C.2
-
25
-
-
11144311055
-
-
Angew. Chem. Int. Ed. 2004, 43, 6358-6360.
-
(2004)
Angew. Chem. Int. Ed.
, vol.43
, pp. 6358-6360
-
-
-
26
-
-
11144287451
-
-
Interestingly, under these conditions, catalyst 1 does not rearrange the enol ester to a 1,3-dicarbonyl compound. For example, see: I. D. Hills, G. C. Fu, Angew. Chem. 2003, 115, 4051-4054;
-
(2003)
Angew. Chem.
, vol.115
, pp. 4051-4054
-
-
Hills, I.D.1
Fu, G.C.2
-
27
-
-
0042819678
-
-
Angew. Chem. Int. Ed. 2003, 42, 3921-3924.
-
(2003)
Angew. Chem. Int. Ed.
, vol.42
, pp. 3921-3924
-
-
-
28
-
-
22744441849
-
-
note
-
3 at 0°C. The resulting solution was stirred at 0°C, and then the reaction was quenched by the addition of MeOH (1 mL). The solvent was removed by rotary evaporation, and the residue was purified by column chromatography.
-
-
-
-
29
-
-
22744452838
-
-
note
-
2; however, not N-methylpyrrolidone); b) Slightly lower ee values were observed at room temperature; c) Typically, ca. 85% of catalyst 1 can be recovered at the end of the reaction.
-
-
-
-
30
-
-
22744451241
-
-
see ref. [4b]
-
These enol esters are more reactive than the aryl esters produced by the addition of 2-iert-butylphenol to ketenes (see ref. [4b]).
-
-
-
-
31
-
-
0037181062
-
-
For other processes catalyzed by 1 that are believed to proceed through chiral enolate A, see: a) B. L. Hodous, G. C. Fu, J. Am. Chem. Soc. 2002, 124, 1578-1579;
-
(2002)
J. Am. Chem. Soc.
, vol.124
, pp. 1578-1579
-
-
Hodous, B.L.1
Fu, G.C.2
-
32
-
-
22744455893
-
-
Ref. [8]
-
b) Ref. [8].
-
-
-
-
33
-
-
22744437923
-
-
For a pioneering study of the O-acylation of enolates by ketenes, see: K. Yoshida, Y. Yamashita, Tetrahedron Lett. 1966, 7, 693-696.
-
(1966)
Tetrahedron Lett.
, vol.7
, pp. 693-696
-
-
Yoshida, K.1
Yamashita, Y.2
-
34
-
-
22744438450
-
-
see ref. [4b]
-
For a process catalyzed by 1 that is believed to proceed through an analogous chiral Brønsted base/acid pathway, see ref. [4b].
-
-
-
-
35
-
-
0000906552
-
-
(Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto), Springer, New York, chapt. 4.1
-
For a review of nonlinear effects in asymmetric catalysis, see: H. B. Kagan, T. O. Luukas in Comprehensive Asymmetric Catalysis (Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto), Springer, New York, 1999, chapt. 4.1.
-
(1999)
Comprehensive Asymmetric Catalysis
-
-
Kagan, H.B.1
Luukas, T.O.2
-
36
-
-
22744446480
-
-
see ref. [4b]
-
This behavior contrasts with enantioselective additions of 2-tert-butylphenol to ketenes catalyzed by 1 in which the catalyst deprotonates the phenol; the mechanism is likely a chiral Brønsted acid catalyzed pathway (see ref. [4b]).
-
-
-
-
37
-
-
22744433304
-
-
note
-
1/2 ≈ 1 h).
-
-
-
|